Literature DB >> 20102226

Peptide-based probes for targeted molecular imaging.

Seulki Lee1, Jin Xie, Xiaoyuan Chen.   

Abstract

Targeted molecular imaging techniques have become indispensable tools in modern diagnostics because they provide accurate and specific diagnosis of disease information. Conventional nonspecific contrast agents suffer from low targeting efficiency; thus, the use of molecularly targeted imaging probes is needed depending on different imaging modalities. Although recent technologies have yielded various strategies for designing smart probes, utilization of peptide-based probes has been most successful. Phage display technology and combinatorial peptide chemistry have profoundly impacted the pool of available targeting peptides for the efficient and specific delivery of imaging labels. To date, selected peptides that target a variety of disease-related receptors and biomarkers are in place. These targeting peptides can be coupled with the appropriate imaging moieties or nanoplatforms on demand with the help of sophisticated bioconjugation or radiolabeling techniques. This review article examines the current trends in peptide-based imaging probes developed for in vivo applications. We discuss the advantage of and challenges in developing peptide-based probes and summarize current systems with respect to their unique design strategies and applications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20102226      PMCID: PMC2829605          DOI: 10.1021/bi901135x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  143 in total

1.  LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases.

Authors:  Carola Leuschner; Challa S S R Kumar; William Hansel; Wole Soboyejo; Jikou Zhou; Josef Hormes
Journal:  Breast Cancer Res Treat       Date:  2006-06-03       Impact factor: 4.872

2.  Dynamic imaging of protease activity with fluorescently quenched activity-based probes.

Authors:  Galia Blum; Stefanie R Mullins; Kinneret Keren; Marko Fonovic; Christopher Jedeszko; Mark J Rice; Bonnie F Sloane; Matthew Bogyo
Journal:  Nat Chem Biol       Date:  2005-08-14       Impact factor: 15.040

Review 3.  Rationale for the use of somatostatin analogs as antitumor agents.

Authors:  C Susini; L Buscail
Journal:  Ann Oncol       Date:  2006-06-26       Impact factor: 32.976

4.  Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects.

Authors:  Weibo Cai; Dong-Woon Shin; Kai Chen; Olivier Gheysens; Qizhen Cao; Shan X Wang; Sanjiv S Gambhir; Xiaoyuan Chen
Journal:  Nano Lett       Date:  2006-04       Impact factor: 11.189

5.  Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.

Authors:  Chunfu Zhang; Manfred Jugold; Eva C Woenne; Twan Lammers; Bernd Morgenstern; Margareta M Mueller; Hanswalter Zentgraf; Michael Bock; Michael Eisenhut; Wolfhard Semmler; Fabian Kiessling
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

Review 6.  Somatostatin receptor imaging.

Authors:  Dik J Kwekkeboom; Eric P Krenning
Journal:  Semin Nucl Med       Date:  2002-04       Impact factor: 4.446

Review 7.  Phage peptide display.

Authors:  Jessica Newton; Susan L Deutscher
Journal:  Handb Exp Pharmacol       Date:  2008

8.  First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography.

Authors:  Margret Schottelius; Thorsten Poethko; Michael Herz; Jean-Claude Reubi; Horst Kessler; Markus Schwaiger; Hans-Jürgen Wester
Journal:  Clin Cancer Res       Date:  2004-06-01       Impact factor: 12.531

9.  Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells.

Authors:  Jin Xie; Kai Chen; Ha-Young Lee; Chenjie Xu; Andrew R Hsu; Sheng Peng; Xiaoyuan Chen; Shouheng Sun
Journal:  J Am Chem Soc       Date:  2008-05-24       Impact factor: 15.419

10.  Requirement of vascular integrin alpha v beta 3 for angiogenesis.

Authors:  P C Brooks; R A Clark; D A Cheresh
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

View more
  70 in total

Review 1.  Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.

Authors:  Xiao-Xiang Zhang; Henry S Eden; Xiaoyuan Chen
Journal:  J Control Release       Date:  2011-10-26       Impact factor: 9.776

2.  One-step (18)F labeling of biomolecules using organotrifluoroborates.

Authors:  Zhibo Liu; Kuo-Shyan Lin; François Bénard; Maral Pourghiasian; Dale O Kiesewetter; David M Perrin; Xiaoyuan Chen
Journal:  Nat Protoc       Date:  2015-08-27       Impact factor: 13.491

3.  Evaluation of novel 99mTc(I)-labeled homobivalent α-melanocyte-stimulating hormone analogs for melanocortin-1 receptor targeting.

Authors:  Maurício Morais; Paula D Raposinho; Maria Cristina Oliveira; João D G Correia; Isabel Santos
Journal:  J Biol Inorg Chem       Date:  2012-04       Impact factor: 3.358

Review 4.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

5.  Synthesis, characterization and biological studies of rhenium, technetium-99m and rhenium-188 pentapeptides.

Authors:  Vanessa A Sanders; David Iskhakov; Dalya Abdel-Atti; Matthew Devany; Michelle C Neary; Ken R Czerwinski; Lynn C Francesconi
Journal:  Nucl Med Biol       Date:  2018-11-12       Impact factor: 2.408

6.  In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides.

Authors:  Jonathan S Wall; Tina Richey; Alan Stuckey; Robert Donnell; Sallie Macy; Emily B Martin; Angela Williams; Keiichi Higuchi; Stephen J Kennel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

7.  High-yielding aqueous 18F-labeling of peptides via Al18F chelation.

Authors:  Christopher A D'Souza; William J McBride; Robert M Sharkey; Louis J Todaro; David M Goldenberg
Journal:  Bioconjug Chem       Date:  2011-08-09       Impact factor: 4.774

Review 8.  Molecular imaging of retinal disease.

Authors:  Megan E Capozzi; Andrew Y Gordon; John S Penn; Ashwath Jayagopal
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-19       Impact factor: 2.671

Review 9.  Advances in molecular imaging: targeted optical contrast agents for cancer diagnostics.

Authors:  Anne Hellebust; Rebecca Richards-Kortum
Journal:  Nanomedicine (Lond)       Date:  2012-03       Impact factor: 5.307

10.  Peptide arrays for development of PDGFRβ Affine molecules.

Authors:  Annabell Marr; Felix Nissen; Daniel Maisch; Annette Altmann; Shoaib Rana; Jürgen Debus; Peter E Huber; Uwe Haberkorn; Vasileios Askoxylakis
Journal:  Mol Imaging Biol       Date:  2013-08       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.